Chemoradiation
Showing 51 - 75 of 1,748
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Cisplatin-based Radiation Therapy
- Cisplatin Chemotherapy
-
Beverly Hills, California
- +3 more
Jul 6, 2022
Rectal Cancer Trial in Alexandria (radiation, drug, procedure)
Completed
- Rectal Cancer
- Radiotherapy
- +2 more
-
Alexandria, EgyptAhmed Samir Ashoor
Mar 7, 2022
Esophageal Adenocarcinoma Trial in Buffalo (Carboplatin, 3 Dimensional Conformal Radiation Therapy, Propranolol)
Recruiting
- Esophageal Adenocarcinoma
- Carboplatin
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 3, 2022
MRI for Selection of Complete Responders After Chemoradiation
Not yet recruiting
- Cancer, Rectum
- MRI
-
Assiut, Egypt
- +1 more
Jan 18, 2022
Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II Trial in Charlottesville (T-DM1, Capecitabine, External Beam
Not yet recruiting
- Breast Cancer
- +3 more
- T-DM1
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Apr 12, 2022
Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)
Recruiting
- Stage III Non-small-cell Lung Cancer
- Neoadjuvant therapy
- +4 more
-
Foshan, Guangdong, China
- +2 more
Oct 25, 2022
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023
Uterine Cervical Tumors Trial in Brazil (Nivolumab 40 mg in 4 ml Injection, Ipilimumab 200 MG in 40 ML Injection,
Not yet recruiting
- Uterine Cervical Neoplasms
- Nivolumab 40 mg in 4 ml Injection
- +2 more
-
Salvador, Bahia, Brazil
- +13 more
Aug 5, 2022
Stage III NSCLC Trial in Guangzhou (Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy)
Recruiting
- Stage III Non-small Cell Lung Cancer
- Neoadjuvant chemo-immunotherapy
- +5 more
-
Guangzhou, ChinaSun Yat-sen University
Jul 19, 2022
Retrospective Cervical Cancer Oligo States Multicentre Outcomes
Not yet recruiting
- Cancer, Cervical
- +2 more
- Concurrent Chemoradiation, Systemic Chemotherapy other locally directed therapies (like surgery, ablation, etc.)
- (no location specified)
Nov 28, 2023
Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500
Recruiting
- Pancreas Adenocarcinoma
- CPI-613® (Dose level -1.0 250 mg/m^2)
- +6 more
-
Detroit, Michigan
- +1 more
Nov 9, 2022
Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer Trial in United States (device, drug, radiation, procedure)
Active, not recruiting
- Non Small Cell Lung Cancer
- Stage III Non-small-cell Lung Cancer
- Durvalumab
- +4 more
-
Chicago, Illinois
- +3 more
Jan 18, 2023
Medical Cannabis During Chemoradiation for Head and Neck Cancer
Recruiting
- Head and Neck Cancer
-
Bronx, New YorkMontefiore Medical Center
Jan 12, 2022
Nasopharyngeal Carcinoma Trial in Nanning (endostar, DDP, IMRT)
Completed
- Nasopharyngeal Carcinoma
- endostar
- +2 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Jan 30, 2022
Gastrointestinal Tumors Trial in Saint Louis (LGG, Placebo)
Terminated
- Gastrointestinal Neoplasms
- LGG
- Placebo
-
Saint Louis, MissouriWashington University School of Medicine
Mar 1, 2022
Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)
Recruiting
- Nasopharyngeal Cancer
- Toripalimab
- Induction chemotherapy and concurrent chemoradiation
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Nov 25, 2022
Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)
Active, not recruiting
- Esophageal Carcinoma
- mFOLFOX6
- Chemoradiation
-
Rochester, New YorkUniversity of Rochester
Aug 17, 2022
Locally Advanced Rectal Cancer Trial (Radiation therapy, chemo and immune checkpoint inhibitor)
Not yet recruiting
- Locally Advanced Rectal Cancer
- Radiation therapy, chemotherapy and immune checkpoint inhibitor
- (no location specified)
Mar 28, 2022
Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine
Active, not recruiting
- Local Advanced High Risk Nasopharyngeal Carcinoma
- IMRT combine with cisplatin concurrent chemotherapy
- IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Mar 13, 2022
Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)
Recruiting
- Stomach Neoplasms
- +7 more
- Oxaliplatin
- +4 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 3, 2021
Head and Neck Squamous Cell Carcinoma Trial in Germany (Pembrolizumab, Lenvatinib)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
-
Augsburg, BY, Germany
- +7 more
Jun 20, 2022
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,
Recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Malignant Neoplasm in the Spine
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 13, 2022
Stage III Non-small-cell Lung Cancer Trial in Providence (Durvalumab, SBRT)
Recruiting
- Stage III Non-small-cell Lung Cancer
- Durvalumab
- SBRT
-
Providence, Rhode Island
- +1 more
Feb 23, 2022
Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Lung Cancer Stage III
- Nivolumab and Chemotherapy
- +3 more
- (no location specified)
Aug 15, 2023